New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
June 29, 2015
09:40 EDTNFLXNetflix moves up off early lows, levels to watch
Shares are down, but off the session low at $637.82 which is now support. At the last price of $644.37, resistance is at $645 and then at $650.
09:35 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:39 EDTMRKMerck says Phase 3 Emend data shows it provides 'greater protection' from nausea
Merck announced results from a Phase 3 study investigating the safety and efficacy of single-dose Emend for Injection, Merck’s substance P/neurokinin receptor antagonist, in combination with other anti-vomiting medicines, for the prevention of chemotherapy-induced nausea and vomiting, or CINV, in adult cancer patients receiving moderately emetogenic chemotherapy, or MEC. In the study, the first to evaluate an intravenous NK-1 receptor antagonist for the prevention of CINV associated with MEC, the single-dose Emend for Injection regimen provided greater protection from nausea and vomiting following administration of chemotherapy versus an active control of placebo with other anti-vomiting medicines. These data were presented in an oral session at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Annual Meeting on “Supportive Care in Cancer” in Copenhagen.
08:02 EDTADNCKnowles announces offer consideration for Audience acquisition
Subscribe for More Information
June 26, 2015
16:32 EDTNFLXStocks end week lower with Greece still searching for deal
Subscribe for More Information
16:00 EDTNFLXOptions Update; June 26, 2015
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
07:52 EDTALKSAlkermes schizophrenia drug profile looks interesting, says Cowen
Subscribe for More Information
June 25, 2015
16:52 EDTNFLXNetflix initiated with a Neutral at Mizuho
Subscribe for More Information
16:00 EDTNFLXOptions Update; June 25, 2015
Subscribe for More Information
10:00 EDTNFLXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:34 EDTNFLXActive equity options trading on open
Active equity options trading on open: AAPL FB NFLX AMZN BAC CVX TWTR INTC GILD BBBY
09:28 EDTNFLXNetflix slips in early trading, levels to watch
Subscribe for More Information
08:07 EDTNFLXNetflix near-term risk/reward neutral, longer outlook upbeat, says Pacific Crest
Subscribe for More Information
07:17 EDTDELLRed Hat to hold a summit
Subscribe for More Information
07:11 EDTNFLXNetflix 'firms up plans' to enter India by 2016, Times of India reports
Netflix has "firmed up plans" to enter India by 2016, The Times of India reports, citing sources familiar with the matter. Reference Link
06:51 EDTNFLXNetflix downgraded to Neutral from Buy at Citi
Citi analyst Mark May downgraded Netflix to Neutral with the stock up 49% since his upgrade on April 10 and 99% year-to-date. May believes more signs of traction in recently launched international markets are needed before shares can reach his upside case of over $950. Further, he points out that the stock has sold off meaningfully following the Q2 and Q3 earnings reports in each of the last three years. May has a $722 price target on the streaming service. Shares of Netflix closed yesterday down $2.58 to $678.61 after billionaire investor Carl Icahn disclosed that he exited his position in the name. Also yesterday, Societe Generale downgraded Netflix to Sell from Buy, saying shares went from undervalued to "pricing perfection."
June 24, 2015
16:21 EDTNFLXOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
16:00 EDTNFLXActionable Options for Wednesday, June, 24
iPath S&P 500 VIX Short-Term Futures up 30c to 17.32 Option volume leaders: AAPL FB NFLX BAC VALE MU BABA WMB T F EBAY FCX TWTR BBRY
13:00 EDTNFLXMark Cuban still owns Netflix, has no attention to sell, CNBC reports
Subscribe for More Information
12:37 EDTNFLXApple where Netflix was a couple of years ago, Icahn says
Subscribe for More Information
12:36 EDTNFLXIcahn says Apple shares still have 'hundreds of points' left
Subscribe for More Information
12:36 EDTNFLXIcahn says Netflix still 'great company,' market overheated
Carl Icahn is speaking on CNBC.
12:30 EDTNFLXOn The Fly: Top stock stories at midday
Subscribe for More Information
12:16 EDTNFLXNetflix gives back most of its gains, levels to watch
Subscribe for More Information
11:58 EDTNFLXNetflix downgraded to Sell from Buy at Societe Generale
Subscribe for More Information
10:48 EDTNFLXNetflix July volatility increases to 56, Icahn says sold last of Netflix stake
Subscribe for More Information
10:44 EDTNFLXCarl Icahn sells last of Netflix stake, positive on Apple
Carl Icahn said via Twitter, "Sold last of our $NFLX today. Believe $AAPL currently represents same opportunity we stated NFLX offered several years ago."
10:43 EDTNFLXCarl Icahn says sold last of Netflix stake today
Subscribe for More Information
09:35 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:10 EDTNFLXOn The Fly: Pre-market Movers
Subscribe for More Information
09:07 EDTMRKCAR-T cancer drug researchers seen as M&A targets, Bloomberg says
Juno Therapeutics (JUNO), Kite Pharma (KITE) and Bluebird Bio (BLUE) are trading well above their IPO levels as takeovers predictions have spurred interest and share increases for the developers of CAR-T gene therapies, said Bloomberg's "Real M&A" column, quoting Dimo Dimov, a professor at the University of Bath’s School of Management, as having said that companies such as Pfizer (PFE), Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) are "closely watching" the firms. Cellectis (CLLS), which is working with Pfizer on its own approach to CAR-T therapy, has said it wants to bring its therapy to market and doesn’t anticipate a sale, the report noted. Reference Link
08:25 EDTNFLXNetflix on pace to have larger audience than all networks, FBR says
FBR Capital analyst Barton Crockett says that while Netflix (NFLX) is not rated by Nielsen (NLSN), the 10B hours streamed in Q1 reported by the company are equivalent to having a 24-hour rating of 2.6, on par with Disney's (DIS) ABC and Comcast's (CMCSA) NBC. And while ratings at broadcasters are falling on average, Netflix is growing its ratings at a 40%-plus compound annual rate, Crockett tells investors this morning in a research note. At this pace, Netflix in a year will have a larger 24-hour audience than all broadcast networks, he contends. Regarding last night's 7-for-1 stock split announcement, Crockett says the move reflects management's confidence in the "durability of the recent stock surge." For perspective, three years ago Netflix shares were around $60. This morning they are trading up $18.69 to $699.88 in the pre-market. Crockett has an Outperform rating on the streaming service with a $900 price target.
08:05 EDTMCK McKesson reaffirms FY16 EPS $12.20-$12.70, consensus $12.59
Subscribe for More Information
07:48 EDTALKSAlkermes data support ALKS 3831 potential, says Credit Suisse
Subscribe for More Information
06:51 EDTNFLXNetflix July volatility at 52 into announcing seven-for-one stock split
Netflix June weekly call option implied volatility is at 23, July is at 52, September is at 38; compared to its 52-week range of 24 to 86, suggesting July price movement into announcing a seven-for-one stock split.
06:09 EDTNFLXOptions expected to be active
Options expected to be active: NFLX SYY MU MON NKE BBBY LEN NBG GREK
05:51 EDTALKSAlkermes physician call on ALKS 3831 encouraging, says UBS
Subscribe for More Information
June 23, 2015
19:03 EDTNFLXOn The Fly: After Hours Movers
UP AFTER PROVIDING GUIDANCE: MeetMe (MEET), up 18.8%. ALSO HIGHER: Nektar Therapeutics (NKTR), up 4.3% after being added to S&P 600... Quidel (QDEL), up 5% after receiving FDA clearance for new Solana molecular system and assay... Vanda Pharmaceuticals (VNDA), up 4.6% after announcing positive results from REPRIEVE study... Netflix (NFLX), up 3.4% after announcing seven-for-one stock split. LOWER: Alcobra (ADHD), down 2.5% after announcing that it will host a conference call and simultaneous webcast presentation to present results from the Phase II clinical trial of MDX... Sysco (SYY), down 2.6% after bid for U.S. foods blocked was blocked by a federal judge... Boeing (BA), down marginally after announcing CEO transition.
16:32 EDTNFLXNetflix up 1.8% after announcing seven-for-one stock split
Subscribe for More Information
16:31 EDTNFLXNetflix announces seven-for-one stock split
Subscribe for More Information
16:30 EDTNFLXNetflix announces seven-for-one stock split
16:29 EDTGDOTOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
16:14 EDTADNCMMCAP International reports 5.66% passive stake in Audience
13:09 EDTNFLXHulu to sell Showtime premium package for subscribers
Hulu (DIS;NWSA;CMSA) will sell Showtime Networks' (CBS) Internet streaming service to subscribers in early July, reports Variety. Hulu will offer Showtime to its subscribers for $8.99 in addition to the $7.99 fee Hulu subscribers pay per month.Reference Link
10:03 EDTGDOTHigh option volume stocks
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:14 EDTGDOTOn The Fly: Pre-market Movers
Subscribe for More Information
07:41 EDTDELLRed Hat to hold a summit
Red Hat Summit 2015 is being held in Boston on June 23-26 with webcasted company presentations to begin on June 23 at 4 pm; not all presentations may be webcasted. Webcast Link
07:05 EDTGDOTGreen Dot price target raised to $24 from $22 at Piper Jaffray
Subscribe for More Information
06:31 EDTGDOTGreen Dot contract terms better than feared, says JPMorgan
Subscribe for More Information
June 22, 2015
19:00 EDTGDOTOn The Fly: After Hours Movers
Subscribe for More Information
16:33 EDTGDOTGreen Dot rallies sharply on Walmart deal
Subscribe for More Information
16:28 EDTGDOTGreen Dot up 27% after announcing deal with Wal-Mart
16:06 EDTGDOTGreen Dot authorizes $150M share repurchase program
Subscribe for More Information
16:02 EDTGDOTGreen Dot to remain program manager for Walmart
Subscribe for More Information
08:17 EDTMCKMcKesson appoints Kathy McElliogott as EVP, CIO, CTO
Subscribe for More Information
07:39 EDTNFLXNetflix price target raised to $950 on business momentum at BTIG
BTIG raised Buy rated Netflix's price target to $950 from $600 citing business model momentum. The firm's analyst believes Netflix can grow substantially beyond 50M domestic subs. In addition, as the MVPD bundle unravels, BTIG expects consumers will have money to spend on Netflix and other SVOD services. As the price/value of Netflix grows, the firm believes there is substantial upside potential to its ARPU estimates. BTIG expects Worldwide streaming subs to expand to over 108M by 2017, up from 101M, compared to 57M at year-end 2014. Furthermore, BTIG believes Netflix could reach 140M global subscribers by 2020.
June 21, 2015
13:14 EDTMRKMerck shares could return 25%, Barron's says
Subscribe for More Information
June 19, 2015
16:00 EDTNFLXOptions Update; June 19, 2015
iPath S&P 500 VIX Short-Term Futures up 11c to 18.21, Option volume leaders: AAPL TWTR BAC T FB GILD NFLX BABA AAL MU AMZN
15:49 EDTMCKMcKesson to host investor day
Investor meeting to be held on June 24 at 9 am. Webcast Link
14:07 EDTNFLXOptions with increasing implied volatility: NFLX CI TRIP AET
10:53 EDTCTRPCtrip.com recent pullback a buying opportunity, says Piper Jaffray
Subscribe for More Information
10:31 EDTALKSAlkermes to host conference call
Conference call to discuss the six-month data of ALKS 3831 for the treatment of schizophrenia will be held on June 23 at 8 am. Webcast Link
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
07:30 EDTNFLXNetflix price target raised to $800 from $610 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his 12-18 month price target for shares of Netflix to $800 from $610. The streaming service closed yesterday up $3.30 to $663.20. The new target reflects the company's plans to enter Japan, Cuba, Spain, Italy and Portugal, all in 2015, the analyst tells investors this morning in a research note. Helfstein's revised model assumes global subscribers of 239M in 2020, equaling 32% penetration of broadband homes, which the analyst says is consistent with Netflix's 2015 rates in older markets. He reiterates an Outperform rating on the stock.
June 18, 2015
11:31 EDTNFLXOptions with increasing implied volatility
Subscribe for More Information
June 17, 2015
17:18 EDTNFLXSpotify hires ex-Netflix CFO Barry McCarthy as company CFO, WSJ says
Subscribe for More Information
17:00 EDTMRKOncoSec CEO expects 'to be in a better position to attract a strategic partner'
Subscribe for More Information
16:56 EDTNFLXSpotify hires ex-Netflix CFO Barry McCarthy as company CFO, Dow Jones says
16:28 EDTCTRPCtrip.com propposes to offer $1B convertible senior notes
Subscribe for More Information
11:08 EDTNFLXOptions with increasing implied volatility
Subscribe for More Information
10:52 EDTALKSAlkermes lower after CEO tells WSJ not interested in selling
Subscribe for More Information
10:32 EDTALKSAlkermes CEO says not interested in selling company, WSJ reports
Subscribe for More Information
10:00 EDTMRKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
09:40 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Active equity options trading on open: AAPL FB AMD ADBE TWTR BABA QIHU NFLX BAC
08:03 EDTMRKMerck Keytruda granted FDA orphan designation as gastric cancer treatment
The FDA granted Merck, Sharp & Dohme, a subsidiary of Merck, orphan status for Keytruda as a treatment of gastric cancer, including gastroesophageal junction adenocarcinoma. Reference Link
06:20 EDTNFLXHulu luring content producers from Netflix, WSJ reports
Subscribe for More Information
05:31 EDTMRKMerck initiated with a Neutral at Piper Jaffray
Subscribe for More Information
June 16, 2015
17:59 EDTMATMattel finds difficulty recruiting supply chain leaders, WSJ says
Subscribe for More Information
16:01 EDTNFLXApple Twitter Facebook Bank of America Yahoo Netflix Alibaba WisdomTree Coca-Cola Goldman Sachs Micron General Electric
iPath S&P 500 VIX Short-Term Futures down 33c to 18.68. Option volume leaders: AAPL TWTR FB BAC YHOO NFLX BABA WETF KO GS MU GE.
15:25 EDTNFLXNetflix rises after analyst downplays impact of Alibaba competition
Subscribe for More Information
11:16 EDTALKSAlkermes says company doesn't comment on rumors, Feuerstein reports
Strength in shares of Alkermes (ALKS) this morning is being attributed by traders to speculation of a takeover. A company spokesperson reportedly told TheStreet's Adam Feuerstein that the company does not comment on rumors or speculation. Shares of Alkermes are up $4.70, or about 8%, to $63.29 in late morning trading. Reference Link
10:18 EDTNFLXOptions with increasing implied volatility
Subscribe for More Information
10:07 EDTMRK, ALKSAlkermes spike attributed to takeover speculation
The spike higher in shares of Alkermes (ALKS) is being attributed by traders to speculation of a takeover. Shares jumped 6% to $61.89 in morning trading. The Ireland based drugmaker focuses on treatments of central nervous system disorders, such as addiction, schizophrenia and depression. The speculative chatter has Merck (MRK) as a potential acquirer of Alkermes. The company’s June 60 and 65 calls are actively trading, according to The Fly's options specialist.
10:06 EDTALKSHigh option volume stocks
Subscribe for More Information
10:01 EDTALKSAlkermes calls active
Alkermes June 60 and 65 calls are active on total call volume of 800 contracts (0 puts) on renewed takeover chatter. June call option implied volatility is at 75, July is at 46, August is at 45; compared to its 52-week range of 33 to 59. Active call volume suggests traders taking positions for large price movement.
09:55 EDTALKSRumor: Alkermes shares active on renewed takeover speculation
Subscribe for More Information
08:47 EDTNFLXNetflix price target raised to $780 from $600 at Needham
Needham analyst Laura Martin raised her price target for shares of Netflix (NFLX) to $780 saying Charter (CHTR) and others offering the streaming service should drive U.S. subscription growth. Further, the company's international subscribers have up to three times faster profit trajectories than their U.S. counterparts, Martin tells investors today in a research note. Netflix will also add advertising revenue "someday," the analyst believes. She keeps a Buy rating on the stock. Netflix shares have sold off recently on Alibaba's (BABA) newly announced streaming service, Martin notes. But she points out China was not in her estimates for Netflix and that she doesn't expect a negative impact on other regions. Shares of Netflix closed yesterday at $654.02.
05:45 EDTNFLXStocks with implied volatility movement; NFLX NBG
Stocks with implied volatility movement; Netflix (NFLX) 46, National Bank of Greece (NBG) 214 according to iVolatility.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use